New Enterprise Associates

New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Peter Barris

Chairman

Forest Baskett

General Partner

Ron Bernal

Venture Partner

Zak Burns

Associate

James Buxton MD

Principal

Carmen Chang

Partner, Chair and Head of Asia

Tak Cheung

Partner

Philip Chopin

Managing Director, NEA UK

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Principal, LP Relations

Tony Florence

General Partner

Jay Graf

Venture Partner

Lily Huang

Principal, Healthcare VC

Arjun Jain

Senior Associate

James Kaplan

Associate

Patrick Kerins

General Partner

Nick Kline

Principal, LP Relations

Vanessa Larco

Partner

Danielle Lay

Principal

Tiffany Le

Senior Associate

Michael Li

Principal

Tiffany Luck

Partner

Mohamad Makhzoumi

General Partner

Matthew McAviney

Partner

Amit Mukherjee

Partner

Bibhash Mukhopadhyay

Principal

Mike O'Dell

Venture Partner

Kemi Odusan

Senior Associate

Greg Papadopoulos

Venture Partner

Luke Pappas

Principal

Michele Park

Partner

Eileen Qian

Associate

Scott Sandell

Managing General Partner

Tim Schaller

CFO

Andrew Schoen

Partner

Jordan Shapiro

Senior Associate

Alex Sharata

Associate

Peter Sonsini

General Partner

George Stamas

Venture Partner

Brad Thawley

Partner, Limited Partner Relations

Lila Tretikov

Partner

Paul Walker

General Partner

Blake Wu

Partner

Lulu Xu

Principal

Rick Yang

Partner, Head of Technology

Emily Zhen

Associate

Ann Bordetsky

Partner

Arno Penzias Ph.D

Venture Partner

J.C. Lopez

Principal

Past deals in Early Venture Stage

Aetherflux

Series A in 2025
Aetherflux develops a novel design for space based solar.

Music AI

Series A in 2025
Music AI is a software development company that provides artificial intelligence solutions for music and audio technology.

Ouro Medicines

Series A in 2025
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.

Sakana AI

Series A in 2024
Sakana AI is an research company focused on creating innovative foundation models inspired by nature. The organization emphasizes evolution and collective intelligence in its AI development processes.

Amber Therapeutics

Series A in 2024
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.

Xaira Therapeutics

Venture Round in 2024
Xaira Therapeutics is an integrated biotechnology company focused on revolutionizing drug discovery and development through the application of artificial intelligence. Headquartered in the San Francisco Bay Area, Xaira combines expertise in machine learning, extensive biological and clinical data generation, and robust therapeutic product development. By harnessing advanced AI techniques, the company aims to enhance the understanding of biological processes and improve the effectiveness of therapies. Xaira's approach encompasses all stages of drug discovery, striving to transform how diseases are treated and enabling clients to deliver innovative therapeutic solutions.

AI Squared

Series A in 2024
AI Squared helps large organizations bring AI to where work happens. We do this by leveraging our SaaS or on-prem platform which combines data sources with advanced AL/ML functionality and embeds intelligent insights into critical business applications. Trusted by the largest financial institutions, the most complicated supply chain logistics companies, and the US Department of Defense, we enable seamless collaboration between data science teams and business users, driving faster, more informed decision-making.

Avenzo

Series A in 2024
Avenzo Therapeutics is a clinical-stage company focused on developing innovative oncology therapies aimed at treating cancer. The company’s platform is dedicated to creating novel treatments specifically for underserved cancers, including rare and genomically defined types. By advancing a pipeline of targeted drug candidates, Avenzo Therapeutics seeks to enhance treatment options for both researchers and patients, addressing significant gaps in current cancer care.

Foundry

Series A in 2024
Foundry is a public cloud supported by an orchestration platform designed to simplify the utilization of AI computing resources. Foundry addresses fundamental economic and technical obstacles encountered in AI and deep learning. Current challenges faced by businesses, such as the notable GPU scarcity and inefficient use of computing capabilities, hinder their effective utilization of resources. Foundry employs pioneering approaches to overcome these hurdles, offering scalable GPU instances with unparalleled price-performance ratios.

Together AI

Series A in 2024
Together AI is a cloud-based platform designed for constructing open-source generative AI and infrastructure for developing AI models. The company contributes cutting-edge open-source research, models, and datasets to push the boundaries of AI forward. Through its decentralized cloud services, developers and researchers at organizations of various scales are empowered to train, refine, and deploy generative AI models.

Mojo Vision

Series A in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

Rocket.Chat

Series A in 2023
Rocket.Chat is an enterprise communication and collaboration platform that serves over 12 million users on more than 500,000 servers globally. It offers an open-source solution designed for team collaboration and omnichannel customer service, enabling users to exchange messages, organize video calls, and share files. The platform supports integration with various external communication tools, allowing companies to customize their communication environment while ensuring data ownership and compliance. Rocket.Chat provides a secure space for both internal and external communications, with features such as individual and group messaging, video conferencing, file uploading, screen sharing, and LiveChat. The company aims to replace traditional email with a real-time federated communications platform and plans to establish a marketplace to facilitate app development and business services built around its core offerings. An active community of over 1,000 developer-contributors continuously enhances the platform, ensuring it meets the evolving needs of its users.

Nexo Therapeutics

Series A in 2023
Nexo Therapeutics is a biotechnology company focused on developing small-molecule therapies for cancer patients who have few effective treatment options. The company utilizes a specialized platform that integrates covalent ligand discovery with chemical biology to create innovative oncology drugs aimed at challenging targets that have been difficult to address in the past. By advancing its pipeline of novel therapies, Nexo Therapeutics seeks to provide new avenues for treatment, ultimately enhancing the care available to individuals battling cancer and other related diseases.

Tagworks Pharmaceuticals

Series A in 2023
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. Tagworks develops In vivo chemistry to improve the efficacy of cancer therapies and to enable novel approaches in companion diagnostics. The company’s facilities are located at the Radboud University Medical Center in Nijmegen. Founded in 2011, Tagworks is a spin-out of Philips Healthcare, and originates from Philips’ molecular imaging expertise.

Djust

Series A in 2023
DJUST is a provider of a cloud-based B2B platform that facilitates the rapid launch of e-commerce and e-procurement solutions for businesses. The company combines digital showrooms, an e-commerce marketplace, and customer relationship management (CRM) tools into a single integrated product. This streamlined approach allows clients to easily set up and expand their online operations, enhancing their ability to engage in digital commerce effectively. By offering a comprehensive solution, DJUST aims to simplify the process for businesses looking to establish or upgrade their online presence.

Granica

Series A in 2023
Granica provides a data readiness platform designed to support enterprises in effectively leveraging artificial intelligence. The platform enables data engineers and leaders to prepare AI-ready data that enhances the efficiency and safety of AI, machine learning, and analytics initiatives. By optimizing data sets for training and inference, Granica reduces storage costs by up to 60% and improves query performance by up to 56%. The company focuses on ensuring data privacy and mitigating the risks of sensitive data leakage while enhancing the accuracy and fairness of AI models. Granica curates and refines training data sets, selecting impactful samples to boost model performance and instill greater trust in AI applications. Targeting industries such as financial services, retail, geo-spatial intelligence, and autonomous vehicles, Granica aims to make AI implementations more effective and beneficial for its clients.

Union.ai

Series A in 2023
Union.ai is a Kubernetes-native workflow orchestration platform for data and machine learning at scale. Union.ai provides software users with the tools they need to move their ideas from concept to high-quality production. Union's aim is to organize the numerous processes required to train and grow the most sophisticated and dynamic machine learning and data products.

Limitless

Series A in 2023
Rewind is a personalized AI powered by everything you’ve seen, said, or heard.

Kira

Venture Round in 2023
Kira Learning is an AI-driven education technology company that creates innovative tools and solutions to support educators and students. Its primary mission is to empower schools, districts, and teachers by integrating cutting-edge artificial intelligence into educational practices, making teaching more effective and learning more engaging.

Kindred

Series A in 2023
Kindred operates a members-only network for house sharing, distinguishing itself from traditional vacation rental platforms. In this unique model, each participant must host their own home to be eligible to stay in another member's property, fostering a higher level of trust among users. The network is designed for individuals seeking a travel-rich lifestyle without the costs associated with hotels or vacation rentals, as there is no financial exchange between guests and hosts. By facilitating home exchanges among trusted peers rather than professional hosts, Kindred creates a community that promotes affordable travel experiences.

SimpleRose

Venture Round in 2023
SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making processes in complex environments. Founded in 2018, the company's solutions focus on optimizing operations through applications such as scheduling, production planning, and portfolio optimization. By leveraging algorithmic innovations for improved numerical accuracy and speed, SimpleRose enables organizations to tackle intricate operational challenges and make informed decisions in real-time.

Perplexity

Series A in 2023
Perplexity is an innovative search engine platform that leverages artificial intelligence, specifically integrating large language models with traditional search functionalities. Utilizing advanced natural language processing and generative AI technologies, Perplexity aims to deliver conversational and contextually relevant responses to user inquiries. The platform is designed to merge the capabilities of conventional search engines with interactive AI assistance, enhancing the user experience. Additionally, Perplexity promotes an open-source environment that facilitates skill development and knowledge acquisition in software development, making its tools accessible to a broader audience. This approach positions Perplexity as a key player in the evolution of AI-driven search technologies.

Relievant Medsystems

Venture Round in 2023
Relievant Medsystems, Inc. is a medical device company focused on developing minimally invasive treatments for chronic axial low back pain. The company has created the Intracept procedure, which specifically targets the basivertebral nerve to alleviate chronic vertebrogenic low back pain. By delivering targeted energy into the spine, the Intracept System effectively blocks the transmission of pain signals, providing patients with a low-risk therapeutic option. Founded in 2004, Relievant is headquartered in Minneapolis, Minnesota, with additional operations in Sunnyvale, California.

OP3N

Series A in 2023
Founded in 2021 as a subsidiary of EST Media Holdings, OP3N is the global Web3 superapp that serves as a one-stop-shop for all communication, connection and commerce with on-chain interactions in a simple unified interface. With a mission to create a more frictionless, decentralized and democratized creator economy on a global scale, OP3N consolidates the tools needed to mint, share and engage with digital goods and digital tokens into one vertical stack. OP3N’s leadership team leverages its cross-industry expertise from the entertainment, gaming and tech ecosystems, to lay the foundations for a new era of community-driven, inclusive entertainment while bringing everyone together on a journey into Web3. OP3N is co-led by media executive, artist, and serial entrepreneur Jaeson Ma, who has a successful track record launching companies including EST Studios, Stampede Ventures, East West Ventures, and 88rising, and who’s raised capital and advised on transactions totaling over $1 billion; and Eric Tu, an award-winning development executive who’s worked with major brands including Nike, Beats by Dre and Google, and as an Executive Producer with Bjork, Radiohead, Kendrick Lamar and more. The company is headquartered in Los Angeles. For more information, please visit: https://op3n.world. OP3N’s portfolio of projects includes a partnership with Tokyo fashion label AMBUSH; an intergalactic children’s book from Grimes; a partnership with entertainment icon Simon Fuller to produce an innovative musical film with the global pop group Now United; and the “Maybe You’re the Problem” music video from the singer-songwriter Ava Max, directed by the celebrated music video director Joseph Kahn.

Fire1

Venture Round in 2023
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

Flox

Series A in 2023
Flox is taking nix to work on building software and managing development environments. The company was founded by Michael Brantley and Ron Efroni in 2018 and is headquartered in New York, United States.

Launchpad Therapeutics

Series A in 2022
Launchpad Therapeutics operates as an antibody-focused precision oncology company.

Fizz

Series A in 2022
Fizz is a social platform that serves as a private discussion forum and news feed for schools. Fizz includes a comprehensive set of features including direct messages, polls, and photos. Fizz communities are secure, authentic, and welcoming, thanks to community-based moderation.

Partiful

Series A in 2022
Partiful is an online platform designed to facilitate the planning and management of social events, including parties and gatherings. The service enables users to create invitations, communicate with guests, and invite friends-of-friends even if their contact information is unavailable. By focusing on the organization of various social events, from intimate dinners to larger parties, Partiful aims to enhance real-world relationships and foster meaningful connections among individuals. The platform provides a streamlined approach to event planning, making it easier for users to cultivate friendships and create memorable experiences.

PixieBrix

Series A in 2022
PixieBrix is a low-code platform that enables users to customize and automate web tools through a browser extension. It allows for the rapid creation of modifications and integrations, enhancing the online experience by adding functionality and streamlining workflows. Targeting both entrepreneurs and large organizations, PixieBrix offers an enterprise-ready solution that can be tailored to meet specific needs. The platform utilizes AI and automation technologies to optimize productivity, ensuring seamless integration with any website for quick implementation and immediate results.

QuoteWell

Series A in 2022
QuoteWell is a digital platform specifically designed for the insurance industry, founded in 2021 and headquartered in Austin, Texas. The company provides a data-driven solution that streamlines the submission process for insurance applications, allowing agents and brokers to efficiently transmit applications to various commercial lines underwriters. By facilitating secure data transfers to multiple carriers, QuoteWell enables users to access a modern risk transfer infrastructure and manage their book of business more effectively.

Code Biotherapeutics

Series A in 2022
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.

Bliq

Series A in 2022
Bliq GmbH, founded in 2019 and based in Berlin, Germany, develops application software tailored for rideshare and delivery drivers. The company's flagship product, the "Bliq Ride" app, enables gig workers in the transport sector to streamline their daily operations by allowing them to accept or reject orders from multiple platforms. By leveraging traffic data and crowd-sourced information, Bliq aims to enhance the productivity and efficiency of its users. With a team of 25 employees, the company continues to focus on supporting the needs of the growing gig economy.

Jomboy Media

Series A in 2022
Jomboy Media is an online media production company that specializes in sports and pop culture content. The company creates and distributes original programming across various formats, including podcasts, digital series, and television shows. Jomboy Media emphasizes topics that resonate with its audience, such as sports, movies, music, and history, fostering an engaging environment for both creators and viewers. By enabling content creators to produce their own shows, Jomboy Media cultivates a diverse range of programming that reflects its passion for these subjects.

Wheelhouse

Series A in 2022
Wheelhouse is a business intelligence platform that helps turn the hosts & owners into superheroes. We're proud that thousands of hosts & owners have used our flagship product, data-driven pricing, to earn significantly more revenue from their business. We're a team of YC alums, data science PhD's, hedge fund engineers, product evangelists, and hustlers. Our teams core values are "empowered together" and "seriously fun". We think that captures the mood & values of a team that works exceptionally well together, pushes the envelope, and is not against cracking a beer together around 5pm on Friday. See more team members here: - https://angel.co/usewheelhouse - https://www.usewheelhouse.com/about-us

NODAR

Series A in 2022
NODAR, Inc. is a Boston-based company that specializes in manufacturing advanced sensors for various transportation modes, including cars, trucks, drones, ships, trains, and aircraft. Established in 2018, NODAR focuses on developing cutting-edge camera-based 3D vision systems aimed at enhancing the safety and reliability of autonomous vehicles. Their flagship product, Hammerhead, utilizes off-the-shelf cameras to deliver long-range, ultra-precise depth sensing essential for Level 3 and Level 4 autonomous applications. This technology enables critical functionalities such as collision warning, path planning, and automatic emergency braking, while ensuring cost-effectiveness and high performance. NODAR's innovations target automotive, marine, and railway industries, providing solutions that meet the growing demand for reliable 3D sensing technology in the mainstream automotive market.

Evernow

Series A in 2022
Evernow is a provider of women's health care services focused on supporting women before, during, and after menopause. The company offers an online teleconsultation platform that connects users with specialized doctors and provides access to science-backed information and treatments. Through this platform, Evernow facilitates conversations about effective care for managing changing hormones, empowering women to lead longer and healthier lives.

Antimatter

Series A in 2022
Antimatter is a cryptographic infrastructure service enabling B2B SaaS companies to provably guarantee the security of their customers' data, fundamentally solving the challenges of data security and privacy requirements without requiring any changes to code. Antimatter was founded in 2021 and is based in Oakland, California.

Clockwork Systems

Series A in 2022
Clockwork Systems is a technology enables next generation time-sensitive applications in on-prem data centers, public clouds, and hybrid environments.

SafeBase

Series A in 2022
SafeBase, Inc. is a company that specializes in developing cloud-based security software aimed at helping organizations establish effective security programs and enhance their credibility with customers. Founded in 2020 and based in San Francisco, California, SafeBase offers a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. Its key features include SafeBase Inspected, which provides a web badge linked to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. The software also aids companies in configuring their security policies, enabling them to adopt robust security practices efficiently.

Alfred

Venture Round in 2022
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.

Weaviate

Series A in 2022
Weaviate is a developer of an open-source AI platform that specializes in creating search and recommendation systems. The company's hybrid SaaS platform features a powerful AI vector search engine, which is designed to handle various use cases, including semantic search. It also includes plugins for integration into different applications and a user-friendly console for data management. Weaviate's architecture allows for efficient scaling, supporting the deployment of machine learning models and handling billions of data objects. This capability enables clients to leverage advanced search functionalities and enhance their applications with effective recommendation systems.

Splice Bio

Series A in 2022
Splice Bio is a biotechnology company based in Barcelona, Spain, focused on developing innovative gene therapies using its proprietary intein platform technology. Founded in 2012 and originally named Proteodesign, S.L., the company aims to address the needs of patients suffering from incurable genetic diseases. The intein platform, developed from research in the Muir Lab at Princeton University, seeks to overcome two significant limitations of traditional adeno-associated virus (AAV) therapies: it enhances the capacity for larger gene delivery and broadens the range of tissues that can be targeted for treatment.

FTX US Derivatives

Series A in 2022
FTX US is a bitcoin options exchange designed to assist both individual traders and institutions in trading. FTX US allows users to trade a variety of digital assets like Bitcoin, Ethereum, Solana, and Dogecoin. The company was founded by Sam Bankman-Fried and Gary Wang in 2020 and is based in San Francisco, California.

Waymark

Series A in 2022
Waymark is a company focused on enhancing access to and the quality of healthcare for individuals receiving Medicaid. It offers community-based healthcare services designed to improve health outcomes for Medicaid beneficiaries. The company collaborates with primary care providers and equips community care teams with essential resources, including health plans, insulin education, and training. Through these efforts, Waymark aims to support patients in effectively managing their health and navigating the healthcare system.

Sorriso Pharmaceuticals

Series A in 2021
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn’s disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system. The company was founded in 2020 and is based in San Diego, California.

Belong Health

Series A in 2021
Belong Health works with local health plans to provide regionally informed, humanistic care to a rapidly expanding community of need.

Wonder

Series A in 2021
Wonder is a company that operates in two distinct sectors: gaming and food delivery. In the gaming industry, Wonder develops an all-in-one platform specifically for Android mobile devices, enabling users to play, stream, and share games seamlessly across different devices, thus enhancing the overall gaming experience. In the food delivery sector, Wonder runs truck-based restaurants that allow consumers to order food via a mobile app. These trucks are dispatched to locations near users’ homes, where they prepare meals on-site to ensure freshness and quality in deliveries. This dual focus on technology and culinary services positions Wonder uniquely in the market, catering to diverse consumer needs.

Tune Therapeutics

Series A in 2021
Tune Therapeutics is focused on developing innovative cell and gene therapies that utilize epigenetic programming to address serious diseases. By harnessing the epigenome, the company aims to create new pathways for treatment without making changes to the DNA sequence itself. This approach allows for the potential development of therapies for complex and widespread medical conditions, positioning Tune Therapeutics at the forefront of advancements in the field of epigenetics.

AviadoBio

Series A in 2021
AviadoBio is focused on developing innovative gene therapies aimed at transforming the lives of individuals affected by neurodegenerative disorders, specifically frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The company leverages advanced research from King's College London and the UK Dementia Research Institute to create its therapeutic platform. By integrating a comprehensive understanding of brain biology with proprietary gene therapy techniques, AviadoBio seeks to address the challenges of effectively delivering treatments to targeted areas in the brain. This approach aims to enhance the therapeutic potential of gene therapies, offering hope for halting or potentially reversing the progression of these debilitating diseases.

Prelay

Series A in 2021
Prelay is a developer of a team selling platform that addresses the challenges revenue teams face in coordinating and communicating with internal stakeholders during the sales process. By consolidating deal management within a single, purpose-built platform, Prelay facilitates organized collaboration, reducing reliance on multiple disjointed tools. This integrated approach not only minimizes complications for sales representatives but also provides leaders in sales, presales, and revenue operations with valuable insights into resource effectiveness and goal achievement. The platform streamlines processes and fosters team alignment, enabling clients to close deals more efficiently and accelerate sales. Prelay is supported by prominent investors, including Y Combinator and executives from leading technology companies.

Recludix Pharma

Series A in 2021
Recludix Pharma is a biotechnology company focused on drug discovery, specifically targeting the development of potent and selective inhibitors for challenging protein targets associated with cancer and autoimmune diseases. The company utilizes a unique platform that combines custom-generated DNA-encoded libraries with massively parallel structure-activity relationship determination and proprietary screening tools. This integrated approach aims to enhance the identification and development of novel small molecule medicines, enabling healthcare professionals to create precision therapies that effectively address specific protein targets in these complex diseases.

Datafold

Series A in 2021
Datafold builds tools for automating analytical data quality management. It helps companies extract more value from their analytical data by automating Data Engineering workflows like data quality monitoring. It also simplifies data QA by enabling instant table comparison and profiling.

Merge

Series A in 2021
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.

Candy

Series A in 2021
Candy Digital is a rapidly growing company specializing in digital collectibles, particularly in the realm of non-fungible tokens (NFTs). Launched in 2021 by notable figures including Fanatics and Gary Vaynerchuk, Candy Digital focuses on creating officially licensed sports NFTs while also expanding into art, entertainment, and music. The company aims to engage fans by offering authentic digital assets that connect them to their passions. In addition to enabling the purchase, sale, and trade of these collectibles, Candy collaborates with athletes, artists, and content creators to produce unique NFT offerings. Led by CEO Scott Lawin, Candy Digital is committed to providing secure and sustainable services within its NFT ecosystem.

Slope.io

Series A in 2021
Slope.io, Inc. is a Mobile, Alabama-based company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016, Slope.io provides a platform that streamlines the operational processes of clinical trials by translating logistical requirements into structured schedules and workflows. The company offers customized supply kits, known as Slope.io Kitting, tailored to specific sites, patients, or study time points. By connecting clinical trials to their supply chains, Slope.io effectively manages the complexity of delivering devices, drugs, and kits from suppliers to research sites and patients, ensuring real-time coordination and complete traceability.

Wizard

Series A in 2021
Wizard is a New York-based commerce technology startup founded in 2021 that focuses on transforming e-commerce through conversational artificial intelligence (AI). The company develops software solutions that enable brands to sell and market their products directly via text messaging. This innovative approach allows clients to engage customers more effectively, resulting in higher conversion rates compared to traditional e-commerce methods.

Neural Magic

Series A in 2021
Neural Magic provides enterprise inference solutions that enhance the performance of open-source large language models across diverse infrastructures. The company's software serves to accelerate artificial intelligence workloads on standard hardware, allowing organizations to efficiently utilize their existing resources. By leveraging big data and deep learning, Neural Magic's technology supports applications such as recommendations, image recognition, and object detection. This enables businesses to overcome the constraints typically associated with traditional hardware accelerators, facilitating secure and cost-effective deployments of AI models.

Workera

Series A in 2021
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes artificial intelligence to offer a detailed assessment of workforce skills, providing hyper-personalized learning plans tailored to individual needs. This approach helps organizations identify skill gaps and mobilize talent effectively, ensuring they remain competitive in a rapidly evolving landscape. Through AI-driven mentorship and adaptive assessments, Workera delivers measurable results that facilitate upskilling and reskilling efforts, ultimately supporting informed decision-making in talent acquisition and development.

Vori Health

Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.

Stablix

Series A in 2021
Stablix Therapeutics is a biotechnology company specializing in Targeted Protein Stabilization (TPS). The company has developed a platform that produces heterobifunctional small molecules, known as RESTORACS, which selectively recruit deubiquitinase enzymes to remove ubiquitin from targeted proteins. This process enhances the stability and activity of these proteins. Stablix focuses on utilizing its innovative technology to create therapeutic programs aimed at treating rare diseases, cancer, and immunological disorders. By restoring protein function, Stablix aims to provide more effective treatment options for complex medical conditions.

Vori Health

Series A in 2021
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.

Goody

Series A in 2021
Goody is a corporate gifting platform that simplifies the process of sending gifts by eliminating the need for recipient addresses. The company offers a diverse selection of curated gifts, ranging from robes and cookies to succulents and spa treatments. This approach allows givers to choose presents without worrying about sizes, as recipients can select their preferred size or swap their gift for another of equal value. Goody's payment system is designed to charge only after the gift has been received, enhancing the experience for both senders and recipients.

Theorycraft Games

Series A in 2021
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Rocket.Chat

Series A in 2021
Rocket.Chat is an enterprise communication and collaboration platform that serves over 12 million users on more than 500,000 servers globally. It offers an open-source solution designed for team collaboration and omnichannel customer service, enabling users to exchange messages, organize video calls, and share files. The platform supports integration with various external communication tools, allowing companies to customize their communication environment while ensuring data ownership and compliance. Rocket.Chat provides a secure space for both internal and external communications, with features such as individual and group messaging, video conferencing, file uploading, screen sharing, and LiveChat. The company aims to replace traditional email with a real-time federated communications platform and plans to establish a marketplace to facilitate app development and business services built around its core offerings. An active community of over 1,000 developer-contributors continuously enhances the platform, ensuring it meets the evolving needs of its users.

Narmi

Series A in 2021
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.

New Wave Foods

Series A in 2021
New Wave Foods is a company that specializes in sustainable, plant-based seafood alternatives. It focuses on creating shrimp substitutes made from sustainably sourced seaweed, soy protein, and natural flavors. These products are designed to preserve and enrich seafood traditions while providing a healthier option for consumers. New Wave Foods' offerings are rich in the essential amino acids typically found in meat, allowing individuals to enjoy low-calorie and zero-cholesterol meals. The company positions itself as a leader in the sustainable seafood sector, catering to the growing demand for environmentally friendly food choices.

POLYNEURON

Series A in 2020
Polyneuron Pharmaceuticals AG is a biotechnology company based in Basel, Switzerland, founded in 2014. The company focuses on developing innovative therapeutics for antibody-mediated autoimmune disorders, particularly those affecting the peripheral nervous system. Its lead candidates include PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron employs a unique platform technology called Antibody-Catch, which utilizes biodegradable glycopolymers to selectively target and eliminate pathogenic autoantibodies while preserving the overall integrity of the immune system. This approach aims to provide safe and effective treatment options for patients suffering from these complex immune disorders.

Korro Bio

Series A in 2020
Korro Bio Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, that specializes in developing nucleic acid-based therapeutics aimed at editing RNA to treat rare and prevalent diseases. Founded in 2018, the company has created a proprietary platform that allows for efficient and selective RNA editing, leveraging natural processes found in multicellular organisms. This innovative approach enables precise modifications to messenger RNA, allowing for targeted changes in protein structure and function across various tissues. By focusing on RNA instead of DNA, Korro Bio aims to enhance the precision and adaptability of genetic medicines, expanding their potential applications in treating a range of medical conditions.

GRID

Series A in 2020
GRID is a spreadsheet technology company redefining how spreadsheets integrate with modern applications. At its core is a powerful independent spreadsheet engine, built for complex calculations, dynamic visualizations, and seamless AI integration.

MBX Biosciences

Series A in 2020
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Monte Rosa Therapeutics

Series A in 2020
Monte Rosa Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that utilize molecular glue degraders (MGDs) to modulate protein degradation pathways. By leveraging the body's natural mechanisms for protein destruction, these small molecule drugs selectively target and degrade disease-causing proteins. The company employs its QuEEN platform, which combines artificial intelligence and proprietary experimental tools, to identify relevant proteins for degradation. With a diverse library of over 50,000 MGD molecules, Monte Rosa's lead candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for treating MYC-driven tumors. The company aims to advance its pipeline of pioneering therapies for cancer and other diseases.

Beyond Identity

Series A in 2020
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.

Vimaan

Series A in 2020
Vimaan is a computer vision and AI solution company focused on enhancing inventory management in warehouses. By automating and digitizing inventory tasks, Vimaan addresses the challenges associated with maintaining accurate stock levels. Their suite of products includes solutions for various applications, such as dock tracking, storage management, and order picking. These tools are designed to support warehousing and logistics companies, ultimately enabling clients to improve the efficiency of their supply chains. Vimaan aims to streamline processes from receiving and storing items to order fulfillment and shipping, thus facilitating better inventory control in a range of industries.

Affinia Therapeutics

Series A in 2020
Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.

ClearMetal

Series A in 2020
ClearMetal, Inc., based in San Francisco, California, specializes in artificial intelligence software for supply chain operations, focusing on transport and supply chain visibility solutions. Founded in 2014 by experts from Stanford University and leading technology companies, ClearMetal's platform leverages machine learning algorithms to enhance the accuracy and quality of ocean freight data. This cloud-based application consolidates and processes information from multiple sources, providing real-time insights into shipment status and enabling organizations to predict arrival times and manage exceptions effectively. By facilitating access to reliable data, ClearMetal aims to improve logistics efficiency and enhance customer experiences in supply chain management.

Dandelion Energy

Series A in 2020
Dandelion Energy, Inc., founded in 2017 and based in Palo Alto, California, specializes in providing affordable geothermal heating and cooling installations. The company has developed a home geothermal system that replaces traditional air conditioning and heating equipment with an efficient heat pump and safe underground pipes. This system harnesses thermal energy from the earth to regulate indoor temperatures and produce hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal solution. Dandelion Energy aims to make renewable energy accessible and cost-effective for residential customers.

Lily AI

Series A in 2020
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.

Anyscale

Series A in 2019
Anyscale, Inc. is a technology company based in Berkeley, California, founded by the creators of the open-source project Ray. It specializes in developing distributed programming platforms and tools that simplify the creation and scaling of artificial intelligence applications. Anyscale's software enables developers and machine learning engineers to effortlessly scale their applications from local environments to the cloud, eliminating the need for complex infrastructure. The company's framework allows users of varying skill levels to build and deploy compute-intensive applications efficiently, facilitating faster and more cost-effective market entry for AI products. Anyscale aims to enhance the end-to-end AI lifecycle, making it accessible for organizations to leverage AI technologies.

Shape Therapeutics

Series A in 2019
Shape Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Seattle, Washington. The company specializes in RNA-editing gene therapy targeting neurodegenerative disorders, oncology, metabolic conditions, and rare genetic diseases. Its proprietary RNAfix technology enables precise editing of RNA using the body's natural cellular mechanisms, which minimizes risks associated with immunogenicity, cellular toxicity, and off-target DNA editing. Shape Therapeutics employs a comprehensive approach to RNA gene therapy, integrating innovative payload, delivery, and manufacturing platform technologies. This strategy aims to facilitate the development of effective treatments and potential cures for a wide range of diseases, with the goal of enhancing patient outcomes across the healthcare landscape.

The Yes

Series A in 2019
They are co-located in Silicon Valley and New York City, but are open to great talent anywhere. They welcome critical thinkers who are excited to re-write the rules of e-commerce. They promise it will be fun.

Genies

Venture Round in 2019
Genies, Inc. is a company that specializes in avatar technology to enhance social media and messaging applications. Founded in 2011 and based in Venice, California, Genies enables users to create personalized digital avatars, which can be utilized for self-expression and interaction in various digital environments. The company has gained traction with cultural influencers and has established partnerships with major music labels, serving as the official avatar provider for artists. Genies recently expanded its offerings with an Augmented Reality (AR) Developer Kit, allowing developers to create interoperable avatar experiences. Their platform includes features for designing digital fashion and engaging in avatar-based interactive experiences. By leveraging its unique technology, Genies facilitates brand engagement and the sale of digital goods, appealing particularly to the college demographic and millennial audience. The company has raised significant investment, achieving a valuation of $1 billion.

Aquabyte

Series A in 2019
Aquabyte, Inc. specializes in developing advanced monitoring systems for the fish farming industry, employing computer vision and machine learning technologies. Founded in 2017 and headquartered in San Francisco, California, with an office in Bergen, Norway, Aquabyte's smart camera system enables real-time applications such as detecting biomass, counting sea lice, and monitoring fish appetite. The accompanying web dashboard provides continuous metrics to enhance operational efficiency. By integrating these technologies, Aquabyte aims to reduce operational costs and fish mortality while promoting sustainability in aquaculture. The company’s innovative approach seeks to address the challenges faced by fish farms, ultimately contributing to a more efficient and environmentally friendly industry.

Vesper Medical

Venture Round in 2019
Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients with deep venous disease and the physicians who treat them. The company's core technology, the Vesper DUO Venous Stent System, is purpose-built for venous stenting, with an unmatched combination of strength and flexibility designed to meet the multiple anatomical challenges presented by vein mechanics. Vesper Medical is advancing the treatment of deep venous disease by creating a highly differentiated, purpose-built venous stent portfolio that addresses the multiple anatomical challenges presented by the iliac and femoral veins. It also develops minimally- invasive peripheral vascular products. Vesper Medical was founded in 2016 and is headquartered in Wayne, PA, USA.

Level

Series A in 2019
Level is a neobank and mobile banking app that provides next-level banking for modern consumers consisting of an app, a cashback debit card called Level Debit Card, and an interest-bearing deposit account called Level Bank Account, offered through Evolve Bank & Trust, Member FDIC. The level is a product of Zero Financial.

ARRIS

Series A in 2019
ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Reneo Pharmaceuticals

Series A in 2019
Reneo Pharmaceuticals is a clinical-stage pharmaceutical company based in San Diego, California, that focuses on developing therapies for patients with rare genetic mitochondrial diseases. These conditions are linked to defects in energy metabolism, leading to issues such as muscle weakness and wasting. The company is developing REN001, an oral drug designed to modulate genes involved in mitochondrial function, aiming to enhance adenosine triphosphate (ATP) production, which is essential for cellular energy. By improving mitochondrial activity, Reneo seeks to enhance the daily functioning and quality of life for patients suffering from these disorders. Founded in 2014, Reneo Pharmaceuticals is committed to addressing the needs of individuals with orphan metabolic diseases.

Spyglass Ophthalmics

Series A in 2019
Spyglass Ophthalmics develops ophthalmic devices intended to improve vision and eye care of patients. Spyglass' devices address unmet needs in cataract, lens replacement, surgery, and other chronic ophthalmic diseases, enabling patients to get quality eye treatment at an affordable cost.

AppSheet

Series A in 2019
AppSheet is the intelligent no-code platform for business apps. It also enables business users to leverage their business data and build powerful, code-free apps. The company connects with a range of data sources including spreadsheets on Google Drive, Office 365, Dropbox, and Box, relational databases like SQLServer, MySQL, Postgres, AWS Aurora, and Oracle, cloud SaaS services like Salesforce, Smartsheet, AirTable, and many more. AppSheet quickly generates a working application that can be customized, enhanced, branded and deployed. The apps can be rich in function (offline access, workflow rules, machine learning, etc) and run on the web, iOS, Android, and messaging platforms. AppSheet was founded in 2014 and is headquartered in Seattle, WA, USA.

Metabase

Series A in 2019
Metabase is an open-source analytics and business intelligence application founded in 2014 and based in San Francisco, California. The platform enables users to create dashboards and reports, facilitating the measurement, analysis, and sharing of data to address complex business challenges. Metabase offers various professional services, including managed hosting and support, as well as assistance with implementing customized analytics solutions. This enables organizations to track data trends over time, enhancing their decision-making processes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.